S&P 500   5,069.34 (+1.76%)
DOW   38,922.94 (+0.80%)
QQQ   436.89 (+2.65%)
AAPL   183.24 (+0.50%)
MSFT   409.70 (+1.87%)
META   487.89 (+4.24%)
GOOGL   143.80 (+0.88%)
AMZN   173.34 (+2.82%)
TSLA   195.76 (+0.51%)
NVDA   775.99 (+15.01%)
NIO   5.76 (-3.52%)
AMD   183.18 (+11.50%)
BABA   75.96 (+0.50%)
T   16.66 (-2.00%)
F   12.17 (+0.25%)
MU   85.74 (+5.22%)
CGC   3.41 (-0.87%)
GE   151.88 (+1.89%)
DIS   107.83 (+0.15%)
AMC   4.40 (-3.72%)
PFE   27.43 (-0.87%)
PYPL   58.43 (+1.65%)
XOM   104.92 (+0.07%)
S&P 500   5,069.34 (+1.76%)
DOW   38,922.94 (+0.80%)
QQQ   436.89 (+2.65%)
AAPL   183.24 (+0.50%)
MSFT   409.70 (+1.87%)
META   487.89 (+4.24%)
GOOGL   143.80 (+0.88%)
AMZN   173.34 (+2.82%)
TSLA   195.76 (+0.51%)
NVDA   775.99 (+15.01%)
NIO   5.76 (-3.52%)
AMD   183.18 (+11.50%)
BABA   75.96 (+0.50%)
T   16.66 (-2.00%)
F   12.17 (+0.25%)
MU   85.74 (+5.22%)
CGC   3.41 (-0.87%)
GE   151.88 (+1.89%)
DIS   107.83 (+0.15%)
AMC   4.40 (-3.72%)
PFE   27.43 (-0.87%)
PYPL   58.43 (+1.65%)
XOM   104.92 (+0.07%)
S&P 500   5,069.34 (+1.76%)
DOW   38,922.94 (+0.80%)
QQQ   436.89 (+2.65%)
AAPL   183.24 (+0.50%)
MSFT   409.70 (+1.87%)
META   487.89 (+4.24%)
GOOGL   143.80 (+0.88%)
AMZN   173.34 (+2.82%)
TSLA   195.76 (+0.51%)
NVDA   775.99 (+15.01%)
NIO   5.76 (-3.52%)
AMD   183.18 (+11.50%)
BABA   75.96 (+0.50%)
T   16.66 (-2.00%)
F   12.17 (+0.25%)
MU   85.74 (+5.22%)
CGC   3.41 (-0.87%)
GE   151.88 (+1.89%)
DIS   107.83 (+0.15%)
AMC   4.40 (-3.72%)
PFE   27.43 (-0.87%)
PYPL   58.43 (+1.65%)
XOM   104.92 (+0.07%)
S&P 500   5,069.34 (+1.76%)
DOW   38,922.94 (+0.80%)
QQQ   436.89 (+2.65%)
AAPL   183.24 (+0.50%)
MSFT   409.70 (+1.87%)
META   487.89 (+4.24%)
GOOGL   143.80 (+0.88%)
AMZN   173.34 (+2.82%)
TSLA   195.76 (+0.51%)
NVDA   775.99 (+15.01%)
NIO   5.76 (-3.52%)
AMD   183.18 (+11.50%)
BABA   75.96 (+0.50%)
T   16.66 (-2.00%)
F   12.17 (+0.25%)
MU   85.74 (+5.22%)
CGC   3.41 (-0.87%)
GE   151.88 (+1.89%)
DIS   107.83 (+0.15%)
AMC   4.40 (-3.72%)
PFE   27.43 (-0.87%)
PYPL   58.43 (+1.65%)
XOM   104.92 (+0.07%)

Cellectis (CLLS) Earnings Date, Estimates & Call Transcripts

$2.85
-0.01 (-0.35%)
(As of 12:20 PM ET)
Skip Charts & View Estimated and Actual Earnings Data

CLLS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CLLS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Cellectis Analyst EPS Estimates

Current Year EPS Consensus Estimate:($1.53) EPS
Next Year EPS Consensus Estimate: ($1.06) EPS

CLLS Earnings Date and Information

Cellectis has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 13th, 2024 based off prior year's report dates.

Cellectis Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/13/2024
Estimated)
------- 
11/6/2023Q3 2023($0.36)($0.31)+$0.05($0.31)$4.03 million$1.64 million
8/3/2023Q2 2023($0.38)($0.14)+$0.24($0.09)$7.80 million$2.00 million
5/4/2023Q1 2023($0.30)($0.58)($0.28)($0.58)$9.30 million$3.56 million
3/8/2023Q4 2022($0.75)($0.57)+$0.18($0.55)$20.48 million$17.32 million
11/3/2022Q3 2022($0.58)($0.63)($0.05)($0.63)$22.45 million$1.92 million
8/4/2022Q2 2022($0.73)($0.42)+$0.31($0.42)$16.50 million$2.77 million
5/12/2022Q1 2022($0.62)($0.70)($0.08)($0.70)$22.85 million$3.83 million
3/3/2022Q4 2021($1.05)($0.55)+$0.50($0.55)$12.30 million$13.66 million    
12/8/2021Q3($0.80)($0.82)($0.02)---    
11/4/2021Q3 2021($0.82)($0.82)-($0.82)$11.50 million$10.83 million    
8/5/2021Q2 2021($0.75)($0.88)($0.13)($0.88)$12.43 million$14.62 million    
5/6/2021Q1 2021($0.82)($0.28)+$0.54($0.28)$8.14 million$27.97 million  
3/4/2021Q4($1.01)($0.95)+$0.06($0.95)$6.25 million$15.63 million  












Cellectis Earnings - Frequently Asked Questions

When is Cellectis's earnings date?

Cellectis has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 13th, 2024 based off last year's report dates. Learn more on CLLS's earnings history.

How much revenue does Cellectis generate each year?

Cellectis (NASDAQ:CLLS) has a recorded annual revenue of $25.73 million.

How much profit does Cellectis generate each year?

Cellectis (NASDAQ:CLLS) has a recorded net income of -$106.14 million. CLLS has generated -$1.67 earnings per share over the last four quarters.

What is Cellectis's EPS forecast for next year?

Cellectis's earnings are expected to grow from ($1.53) per share to ($1.06) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:CLLS) was last updated on 2/22/2024 by MarketBeat.com Staff